A phase II feasibility trial of TS-1/PSK therapy as adjuvant chemotherapy for gastric cancer with TS-1/CDDP as neoadjuvant chemotherapy.
Phase 2
- Conditions
- Gastric cancer
- Registration Number
- JPRN-UMIN000004266
- Lead Sponsor
- Department of Gastroenterological Surgery Graduate School of Medicine Osaka University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1.Double cancer. 2.Patients with administration contraindication of TS-1. 3.Patients who need continuing use of flucytosine, phenytoin, warfarin potassium. 4.Patients with severe complication (such as ileus, interstitial lung disease, lung fibrosis, diabetes that is difficult to control, heart failure, renal failure, liver failure). 5.Pregnant or lactating patients. 6.Male who have intention that get with child. 7.Patients who are not suitable for this trial by doctor's judgment.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Adverse event and its frequency 2.Medication compliance (Relative performance: RP%) 3.Recurrence-free survival time and survival time
- Secondary Outcome Measures
Name Time Method